Support pathway for patients with ENT cancer
Official title: Support Pathway for ENT Cancer Patients in a Support Care Day Hospital Single-centre Prospective Randomised Interventional Study
Run by Clinique Pasteur Lanroze · NCT06512662 · Data updated 2026-11-12
This study is testing whether a new, more complete support system for patients with ENT cancer before and after surgery can help reduce anxiety and improve their quality of life compared to standard care.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 18 Years and up |
| Sex | All |
| Enrollment | 60 (estimated) |
| Sponsor | Clinique Pasteur Lanroze Academic / other |
| Locations | 1 site (Brest) |
| Status | Recruiting |
| Started | October 8, 2024 |
| Main results expected | December 31, 2026 |
| Study ends | March 31, 2027 |
| Registry record updated | April 6, 2026 |
| Trial ID | NCT06512662 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates are patients scheduled for surgery for VADS cancer who require at least one night of post-operative hospitalization and can understand French.
✕Probably not a fit
Patients with major cognitive disorders or significant anxiety disorders prior to cancer diagnosis may not benefit from this study.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This study aims to compare the standard pre-operative supportive care with a more comprehensive interdisciplinary care pathway for patients undergoing surgery for cancers of the upper respiratory and digestive tract. The focus is on reducing anxiety and improving the quality of life through additional post-operative day hospital consultations. By assessing the impact of these interventions, the study seeks to address the psychological, physical, and social challenges faced by patients during their treatment journey.
Why it matters
Potential benefit: If successful, this approach could significantly reduce anxiety and enhance the quality of life for patients undergoing surgery for ENT cancers.
How similar studies have gone: While similar supportive care approaches have shown promise in improving patient outcomes, this specific intervention is novel and has not been extensively tested.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * patient undergoing surgery for VADS cancer requiring at least one night's post-operative hospitalisation * Understanding of spoken and written French * Patient covered by a social security scheme Exclusion Criteria: * Protected patient under a protective measure or legal safeguard * Pregnant or breast-feeding patients * Patients suffering from major cognitive disorders * Patients with major anxiety disorders prior to the onset of cancer
Where it's running
-
Clinique Pasteur Lanroze
Brest, France Recruiting
Study contacts
- Study coordinator: Camille Vuarin, APN
- Email: cvuarin@chp-brest.bzh
- Phone: +33 2 98 34 20 31
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.